Back to RNA
GOLDMAN SACHS GROUP INC RNA Position History
Atrium Therapeutics, Inc. • Healthcare
Quarters held
4
Latest value
$765K
Q2 2026
Peak value
$4.2M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $4.2M |
| Q1 2026 | $462K |
| Q2 2026 | $3.4M |
| Q2 2026 | $765K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $765K | 56.9K | — | — |
| Q2 2026 | $3.4M | 253.5K | — | — |
| Q1 2026 | $462K | 34.6K | — | — |
| Q1 2026 | $4.2M | 315.4K | — | — |